These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36534125)
41. Treatment strategies and outcomes in patients with infected aortic endografts. Fatima J; Duncan AA; de Grandis E; Oderich GS; Kalra M; Gloviczki P; Bower TC J Vasc Surg; 2013 Aug; 58(2):371-9. PubMed ID: 23756338 [TBL] [Abstract][Full Text] [Related]
42. Early host tissue response to different types of vascular prostheses coated with silver acetate or vaporized metallic silver. Jeanmonod P; Laschke MW; Gola N; von Heesen M; Glanemann M; Menger MD; Moussavian MR Eur J Vasc Endovasc Surg; 2014 Jun; 47(6):680-8. PubMed ID: 24726145 [TBL] [Abstract][Full Text] [Related]
43. Vascular Graft Infections: Updates on a Challenging Problem. Abdul Halim R; Challita C; Omeirat N; Kanafani ZA Infect Dis Clin North Am; 2024 Dec; 38(4):657-671. PubMed ID: 39261139 [TBL] [Abstract][Full Text] [Related]
44. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection? Vicaretti M; Hawthorne W; Ao PY; Fletcher JP Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422 [TBL] [Abstract][Full Text] [Related]
49. Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Joint Vascular Research Group. Braithwaite BD; Davies B; Heather BP; Earnshaw JJ Br J Surg; 1998 Oct; 85(10):1378-81. PubMed ID: 9782018 [TBL] [Abstract][Full Text] [Related]
50. Editor's Choice - Treatment of Aortic Prosthesis Infections by Graft Removal and In Situ Replacement with Autologous Femoral Veins and Fascial Strengthening. Heinola I; Kantonen I; Jaroma M; Albäck A; Vikatmaa P; Aho P; Venermo M Eur J Vasc Endovasc Surg; 2016 Feb; 51(2):232-9. PubMed ID: 26541862 [TBL] [Abstract][Full Text] [Related]
51. Treatment of aortic graft infection by in situ reconstruction with Omniflow II biosynthetic prosthesis. Krasznai AG; Snoeijs M; Siroen MP; Sigterman T; Korsten A; Moll FL; Bouwman LH Vascular; 2016 Dec; 24(6):561-566. PubMed ID: 26647420 [TBL] [Abstract][Full Text] [Related]
52. In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results. Torsello G; Sandmann W; Gehrt A; Jungblut RM J Vasc Surg; 1993 Apr; 17(4):768-73. PubMed ID: 8464099 [TBL] [Abstract][Full Text] [Related]
53. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. Oderich GS; Bower TC; Hofer J; Kalra M; Duncan AA; Wilson JW; Cha S; Gloviczki P J Vasc Surg; 2011 Jan; 53(1):99-106, 107.e1-7; discussion 106-7. PubMed ID: 21184932 [TBL] [Abstract][Full Text] [Related]